There is a case report describing DKA in type 2 diabetes patients after stopping insulin and initiating dulaglutide therapy.[17] Recently, no large sample study has been conducted to demonstrate the relationship between GLP1 receptor agonists and DKA, and this remains unknown. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.